In recurrent ovarian cancer patients, the study shows success in providing patients with NGS-directed therapy. Molecular profiling can play an important role in making treatment decisions and will be a critical component in optimizing personalized medicine cancer care. Utilizing personalized medicine in high-volume clinical environments requires interdisciplinary expertise. The lack of an organized infrastructure in performing next generation sequencing (NGS), integrating these results into the electronic medical record (EMR), and guiding clinicians on how to interpret these tests for clinical decision making remains a barrier in the implementation of personalized medicine.
For more updates https://www.scitechnol.com/theranostics-international-journal.php